CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes
ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes the design and outcomes of the latest “Trial of the month” featured in ISN-ACT GTF. Trial of the month: Stronger together: Finerenone & empagliflozin boost kidney outcomes in diabetes Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes Agarwal R, et al., N Engl J...